Skip to content

Ayurvedic treatment with physiotherapy -New treatment for the management of Rheumatoid Arthritis

An Open Labelled Randomized Comparative Clinical Study to Evaluate Add- on Efficacy of Physiotherapy with Vaitarana Basti in The Management of Amavata w.s.r. to Rheumatoid Arthritis. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086316
Enrollment
40
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Akshay Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of either gender between the age group of 18 to 60 years. 2. Patient diagnosed to have Rheumatoid Arthritis as per ACR 2010. 3. Patient with the classical symptoms of Amavata. 4. Ability to Provide Informed Consent: Participants must be capable of understanding the study and providing informed consent. 5. Willingness to Comply with Study Protocol: Participants must agree to follow the study procedures, including attending follow-up visits and adhering to prescribed treatments.

Exclusion criteria

Exclusion criteria: 1. Patient who is unfit to take Vaitarana Basti like hemorrhoids, prolapse of rectum, Ca rectum. 2. Patient unfit to take physiotherapy like dislocation of the joints. 3. Patients suffering uncontrolled diabetes mellitus & Hypertension. 4. Patients suffering with Severe metabolic disorders and Psychiatric disorders and Malignancy 5. Patient suffering with other joint disorders like osteoarthritis, gouty arthritis and psoriatic arthritis, 6. Rheumatoid arthritis with chronicity of more than 1 years. 7. Patient with a history Leprosy, HIV-AIDS, HbSAg and other immune-compromised conditions. 8. Patient with open wounds, infective conditions, allergic rashes, deep vein thrombosis, impaired sensations and acute dermatitis.

Design outcomes

Primary

MeasureTime frame
1.Reduction in the Disease activity score(DAS 28) 2.Instant relief in joint pain with reduced visual analogue score(PAIN SCALE)Timepoint: 1.Reduction in the Disease activity score(DAS 28) - Baseline, 8th Day, 24th day 2.Instant relief in joint pain with reduced visual analogue score(PAIN SCALE) and improvement in the ROM of joints. - Baseline, 4th day, 8th day, 24th day.

Secondary

MeasureTime frame
Assessment of Samyak Niruha and Anuvasana Basti LakshanasTimepoint: Everyday- from 1st -8th day of intervention

Countries

India

Contacts

Public ContactDr Divya B

Parul Institute of Ayurved and Research

dr.divyadeva3@gmail.com9844810958

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026